Clinical trials: Surfactant Administration by Aerosolization

Respiratory Distress Syndrome, Surfactant Administration by Aerosolization

Does The Surfactant Administration by Aerosolization Effective?

• Unknown status
• Age: 26 to 34 weeks
• Medical device

The present study was designed to evaluate, in premature babies with RDS breathing spontaneously, the efficacy of combined treatment with nasal continuous positive airway pressure (CPAP) and aerosolized surfactant.

Trial name

NCT02825953

Testing

surfactant, nasal continuous positive airway pressure, non-invasive intermittent positive-pressure ventilation

Volunteers

75 people

Sponsor

nihat demir